These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26830608)

  • 21. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
    Hohmann J; Skrok J; Puls R; Albrecht T
    Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benign hepatic nodular lesions after treatment for childhood cancer.
    Masetti R; Colecchia A; Rondelli R; Martoni A; Vendemini F; Biagi C; Prete A; Festi D; Lima M; Pession A
    J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):151-5. PubMed ID: 22922376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Focal nodular hyperplasia and hepatic adenoma: differentiation with low-mechanical-index contrast-enhanced sonography.
    Kim TK; Jang HJ; Burns PN; Murphy-Lavallee J; Wilson SR
    AJR Am J Roentgenol; 2008 Jan; 190(1):58-66. PubMed ID: 18094294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical features and treatment of hepatic tumor-like lesions].
    Guo RP; Zhong C; Shi M; Wei W; Zhang YQ; Li JQ; Li GH
    Ai Zheng; 2006 Mar; 25(3):352-4. PubMed ID: 16536993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast enhanced ultrasound (CEUS) characterization of grey-scale sonographic indeterminate focal liver lesions in pediatric practice.
    Jacob J; Deganello A; Sellars ME; Hadzic N; Sidhu PS
    Ultraschall Med; 2013 Dec; 34(6):529-40. PubMed ID: 24132647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of diffusion-weighted imaging in characterizing focal liver masses.
    Sandrasegaran K; Akisik FM; Lin C; Tahir B; Rajan J; Aisen AM
    Acad Radiol; 2009 Oct; 16(10):1208-14. PubMed ID: 19608435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The angiographic findings in focal nodular hyperplasia of the liver(author's transl)].
    Zurbriggen S; Tylén U
    Rofo; 1975 May; 122(5):404-9. PubMed ID: 169193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of diagnostic performance of unenhanced vs SonoVue - enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers.
    Quaia E; Stacul F; Gaiani S; Ricci P; Passariello R; Curzio D; Pozzi Mucelli R
    Radiol Med; 2004; 108(1-2):71-81. PubMed ID: 15269691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Unknown liver lesions].
    Roderburg C; Loosen SH; Bruners P; Luedde T
    Dtsch Med Wochenschr; 2019 Nov; 144(23):1651-1664. PubMed ID: 31752038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unclear focal liver lesions in contrast-enhanced ultrasonography--lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors.
    Bernatik T; Seitz K; Blank W; Schuler A; Dietrich CF; Strobel D
    Ultraschall Med; 2010 Dec; 31(6):577-81. PubMed ID: 20740399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical treatment of benign hepatic mass lesions.
    Arnoletti JP; Brodsky J
    Am Surg; 1999 May; 65(5):431-3. PubMed ID: 10231211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A triple stain of reticulin, glypican-3, and glutamine synthetase: a useful aid in the diagnosis of liver lesions.
    Swanson BJ; Yearsley MM; Marsh W; Frankel WL
    Arch Pathol Lab Med; 2015 Apr; 139(4):537-42. PubMed ID: 25822763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Oral contraceptives and benign tumorous conditions of the liver (author's transl)].
    Lesch R; Hoppe-Seyler P; Heissmeyer HH; Hoensch D; Jenss H; Wimmer B; Wenz W
    Radiologe; 1980 Dec; 20(12):565-76. PubMed ID: 7208890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypervascular liver masses on contrast-enhanced ultrasound: the importance of washout.
    Bhayana D; Kim TK; Jang HJ; Burns PN; Wilson SR
    AJR Am J Roentgenol; 2010 Apr; 194(4):977-83. PubMed ID: 20308500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ultrasonography in differential diagnosis of focal liver neoplasms].
    Medzhidov RT; Khabibulaeva ZR; Sagidullaeva GA
    Khirurgiia (Mosk); 2008; (7):48-53. PubMed ID: 18833165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computer-aided image analysis of focal hepatic lesions in ultrasonography: preliminary results.
    Kim SH; Lee JM; Kim KG; Kim JH; Lee JY; Han JK; Choi BI
    Abdom Imaging; 2009; 34(2):183-91. PubMed ID: 18386094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of focal hepatic lesions with ferumoxides-enhanced T2-weighted MR imaging.
    Paley MR; Mergo PJ; Torres GM; Ros PR
    AJR Am J Roentgenol; 2000 Jul; 175(1):159-63. PubMed ID: 10882267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contrast-enhanced ultrasound in combination with color Doppler ultrasound can improve the diagnostic performance of focal nodular hyperplasia and hepatocellular adenoma.
    Kong WT; Wang WP; Huang BJ; Ding H; Mao F; Si Q
    Ultrasound Med Biol; 2015 Apr; 41(4):944-51. PubMed ID: 25701530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of focal hepatic lesions with ultrasound contrast agents.
    Sutherland T; Temple F; Lee WK; Hennessy O
    J Clin Ultrasound; 2011 Sep; 39(7):399-407. PubMed ID: 21674510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Focal nodular hyperplasia of the liver: pathological analysis of 11 cases.
    Pan Y; Wang ZM; Mou LJ; Teng XD; Zheng ZJ; Ying LX
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):199-203. PubMed ID: 15138109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.